Triple agonist at GLP-1R (appetite suppression), GIPR (insulin sensitization), and GCGR (hepatic lipolysis and energy expenditure)
While the overall evidence is promising, to move from promise to practice, future multicenter, long-term RCTs, standardizing the dosage and formulation of L-carnitine should be a top priority for future large-scale trials
Speak to your provider Dr

Progressive Enhancement : Your treatment plan evolves as your weight loss progresses: Initial focus may be preventative biostimulation with minimal fillers Mid-journey adjustments might include more targeted volume replacement Later stages often incorporate more intensive skin tightening Clinical Evidence Supporting Combined Approaches: The 2025 Galderma study specifically utilised a combined protocol where patients received: Sculptra and either Restylane Lyft or Contour for their first treatment A second Sculptra treatment with optional Restylane touch-up at Week 4 An optional third Sculptra treatment at Week 8 This integrated approach delivered impressive results: Significant improvements in facial contour and skin quality 85% of patients reporting a more refreshed appearance by Week 4 89% feeling more attractive with natural-looking results at three months Personalised Treatment Combinations by Patient Profile At Aestha Clinic, we create truly customised treatment plans that mix and match from our toolkit based on your unique needs

If gastrointestinal side effects from GLP-1 medications are significant, patients should discuss with their GP whether the timing of levothyroxine administration needs adjustment
But because it has next to no flavor, you can add it to just about anything